Standard
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer. / Denholt, Charlotte Lund; Binderup, Tina; Stockhausen, Marie-Thérése; Poulsen, Hans Skovgaard; Spang-Thomsen, Mogens; Hansen, Paul Robert; Gillings, Nicholas Mathew; Kjær, Andreas.
In:
Nuclear Medicine and Biology, Vol. 38, No. 4, 2011, p. 509-515.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Denholt, CL
, Binderup, T, Stockhausen, M-T, Poulsen, HS, Spang-Thomsen, M
, Hansen, PR, Gillings, NM
& Kjær, A 2011, '
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer',
Nuclear Medicine and Biology, vol. 38, no. 4, pp. 509-515.
https://doi.org/10.1016/j.nucmedbio.2010.11.003APA
Denholt, C. L.
, Binderup, T., Stockhausen, M-T., Poulsen, H. S., Spang-Thomsen, M.
, Hansen, P. R., Gillings, N. M.
, & Kjær, A. (2011).
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Nuclear Medicine and Biology,
38(4), 509-515.
https://doi.org/10.1016/j.nucmedbio.2010.11.003Vancouver
Denholt CL
, Binderup T, Stockhausen M-T, Poulsen HS, Spang-Thomsen M
, Hansen PR et al.
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Nuclear Medicine and Biology. 2011;38(4):509-515.
https://doi.org/10.1016/j.nucmedbio.2010.11.003Author
Denholt, Charlotte Lund ; Binderup, Tina ; Stockhausen, Marie-Thérése ; Poulsen, Hans Skovgaard ; Spang-Thomsen, Mogens ; Hansen, Paul Robert ; Gillings, Nicholas Mathew ; Kjær, Andreas. / Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer. In: Nuclear Medicine and Biology. 2011 ; Vol. 38, No. 4. pp. 509-515.
Bibtex
@article{8dc40f20280440938a148347398195c9,
title = "Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer",
abstract = "This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII.",
author = "Denholt, {Charlotte Lund} and Tina Binderup and Marie-Th{\'e}r{\'e}se Stockhausen and Poulsen, {Hans Skovgaard} and Mogens Spang-Thomsen and Hansen, {Paul Robert} and Gillings, {Nicholas Mathew} and Andreas Kj{\ae}r",
note = "Copyright {\textcopyright} 2011 Elsevier Inc. All rights reserved.",
year = "2011",
doi = "10.1016/j.nucmedbio.2010.11.003",
language = "English",
volume = "38",
pages = "509--515",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier",
number = "4",
}
RIS
TY - JOUR
T1 - Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer
AU - Denholt, Charlotte Lund
AU - Binderup, Tina
AU - Stockhausen, Marie-Thérése
AU - Poulsen, Hans Skovgaard
AU - Spang-Thomsen, Mogens
AU - Hansen, Paul Robert
AU - Gillings, Nicholas Mathew
AU - Kjær, Andreas
N1 - Copyright © 2011 Elsevier Inc. All rights reserved.
PY - 2011
Y1 - 2011
N2 - This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII.
AB - This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII.
U2 - 10.1016/j.nucmedbio.2010.11.003
DO - 10.1016/j.nucmedbio.2010.11.003
M3 - Journal article
C2 - 21531288
VL - 38
SP - 509
EP - 515
JO - Nuclear Medicine and Biology
JF - Nuclear Medicine and Biology
SN - 0969-8051
IS - 4
ER -
